The Alternatives to PAIN Act would modify Medicare's prescription drug coverage (Part D) to make non-opioid pain management medications more accessible and affordable for seniors starting in January 2025. The bill would eliminate deductibles for qualifying non-opioid pain drugs, place them on the lowest cost-sharing tier possible, and prohibit insurance plans from requiring patients to try opioids first or obtain prior authorization before using these medications. Qualifying drugs are defined as FDA-approved non-opioid medications for acute or postoperative pain that have no therapeutically equivalent alternatives already on the market and meet certain cost thresholds. This legislation aims to expand alternatives to opioids for Medicare beneficiaries dealing with pain while potentially reducing their out-of-pocket costs. The bill was introduced in February 2024 and referred to the Senate Committee on Finance.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.